Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Corneal Toxicity”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT01263262
What this trial is testing

A Comparison of Infection Rates Between Two Surgical Sites

Who this might be right for
Corneal ToxicityOtotoxicitySurgical Site Infection
Mayo Clinic 600
Testing effectiveness (Phase 2)WithdrawnNCT02126020
What this trial is testing

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis (Lyell) SyndromeMucous Membrane Pemphigoid
James Chodosh, MD, MPH
Testing effectiveness (Phase 2)Study completedNCT00001213
What this trial is testing

Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis

Who this might be right for
Cystinosis
National Eye Institute (NEI) 328
Not applicableUnknownNCT00892918
What this trial is testing

Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision

Who this might be right for
Primary Pterygium
Meir Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02592330
What this trial is testing

Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft

Who this might be right for
Limbal Stem Cell Deficiency
Massachusetts Eye and Ear Infirmary 23
Not applicableStudy completedNCT05887206
What this trial is testing

Corneal Toxicity in Patients Treated by Belantamab Mafodotin

Who this might be right for
Myeloma Multiple
Centre Hospitalier Universitaire de Saint Etienne 43
Testing effectiveness (Phase 2)WithdrawnNCT01256489
What this trial is testing

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Who this might be right for
Stevens-Johnson SyndromeCorneal Blindness
Massachusetts Eye and Ear Infirmary
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000